Loss of PDPK1 Abrogates Resistance to Gemcitabine in Label-Retaining Pancreatic Cancer Cells
BMC Cancer - United Kingdom
doi 10.1186/s12885-018-4690-1
Full Text
Open PDFAbstract
Available in full text
Date
July 31, 2018
Authors
Publisher
Springer Science and Business Media LLC